APA (7th ed.) Citation

S, H., M, Z., R, H., Y, L., S, V., J, M., . . . J, Z. (2021). AZD5438-PROTAC: A selective CDK2 degrader that protects against cisplatin- and noise-induced hearing loss. European journal of medicinal chemistry, 226, 113849. https://doi.org/10.1016/j.ejmech.2021.113849

Chicago Style (17th ed.) Citation

S, Hati, Zallocchi M, Hazlitt R, Li Y, Vijayakumar S, Min J, Rankovic Z, Lovas S, and Zuo J. "AZD5438-PROTAC: A Selective CDK2 Degrader That Protects Against Cisplatin- and Noise-induced Hearing Loss." European Journal of Medicinal Chemistry 226 (2021): 113849. https://doi.org/10.1016/j.ejmech.2021.113849.

MLA (9th ed.) Citation

S, Hati, et al. "AZD5438-PROTAC: A Selective CDK2 Degrader That Protects Against Cisplatin- and Noise-induced Hearing Loss." European Journal of Medicinal Chemistry, vol. 226, 2021, p. 113849, https://doi.org/10.1016/j.ejmech.2021.113849.

Warning: These citations may not always be 100% accurate.